{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T21:23:23Z","timestamp":1783113803371,"version":"3.54.6"},"reference-count":23,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1016\/j.jaci.2016.09.051","type":"journal-article","created":{"date-parts":[[2016,11,29]],"date-time":"2016-11-29T14:18:19Z","timestamp":1480429099000},"page":"242-248.e2","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":88,"title":["Effect of bradykinin receptor antagonism on ACE inhibitor-associated angioedema"],"prefix":"10.1016","volume":"140","author":[{"given":"Brittany T.","family":"Straka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia E.","family":"Ramirez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James B.","family":"Byrd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Stone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alencia","family":"Woodard-Grice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Nian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleena","family":"Banerji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy J.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaci.2016.09.051_bib1","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.iac.2006.08.001","article-title":"Angiotensin-converting enzyme inhibitor-associated angioedema","volume":"26","author":"Byrd","year":"2006","journal-title":"Immunol Allergy Clin North Am"},{"key":"10.1016\/j.jaci.2016.09.051_bib2","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/(SICI)1099-1557(199605)5:3<149::AID-PDS222>3.0.CO;2-I","article-title":"Angiotensin converting enzyme inhibitor-associated angioedema: higher risk in blacks than whites","volume":"5","author":"Burkhart","year":"1996","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.jaci.2016.09.051_bib3","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1056\/NEJMcp0803977","article-title":"Clinical practice: hereditary angioedema","volume":"359","author":"Zuraw","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2016.09.051_bib4","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1056\/NEJM199810293391804","article-title":"Effect of bradykinin-receptor blockade on the response to angiotensin-converting-enzyme inhibitor in normotensive and hypertensive subjects","volume":"339","author":"Gainer","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2016.09.051_bib5","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1161\/01.CIR.0000046268.59922.A4","article-title":"Angiotensin-converting enzyme inhibition increases human vascular tissue-type plasminogen activator release through endogenous bradykinin","volume":"107","author":"Pretorius","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.jaci.2016.09.051_bib6","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/S0022-3565(24)34947-X","article-title":"Bradykinin activates a cross-signaling pathway\u00a0between sensory and adrenergic nerve endings in the heart: a novel mechanism of ischemic norepinephrine release?","volume":"290","author":"Seyedi","year":"1999","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.jaci.2016.09.051_bib7","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1124\/jpet.103.064105","article-title":"The effect of acute angiotensin-converting enzyme and neutral endopeptidase 24.11 inhibition on plasma extravasation in the rat","volume":"309","author":"Sulpizio","year":"2004","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.jaci.2016.09.051_bib8","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.jaci.2007.04.012","article-title":"Dipeptidyl peptidase IV deficiency increases susceptibility to angiotensin-converting enzyme inhibitor-induced peritracheal edema","volume":"120","author":"Byrd","year":"2007","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2016.09.051_bib9","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1161\/hc4301.098252","article-title":"Bradykinin contributes to the vasodilator effects of chronic angiotensin-converting enzyme inhibition in patients with heart failure","volume":"104","author":"Witherow","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.jaci.2016.09.051_bib10","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1056\/NEJMoa0906393","article-title":"Icatibant, a new bradykinin-receptor antagonist, in hereditary angioedema","volume":"363","author":"Cicardi","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2016.09.051_bib11","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.anai.2011.08.015","article-title":"Randomized placebo-controlled trial of the bradykinin B2 receptor antagonist icatibant for the treatment of acute attacks of hereditary angioedema: the FAST-3 trial","volume":"107","author":"Lumry","year":"2011","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaci.2016.09.051_bib12","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1056\/NEJMoa1312524","article-title":"A randomized trial of icatibant in ACE-inhibitor-induced angioedema","volume":"372","author":"Bas","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2016.09.051_bib13","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/S0009-9236(96)90161-7","article-title":"Black Americans have an increased rate of angiotensin converting enzyme inhibitor-associated angioedema","volume":"60","author":"Brown","year":"1996","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.jaci.2016.09.051_bib14","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1001\/archinte.165.14.1637","article-title":"Incidence and characteristics of angioedema associated with enalapril","volume":"165","author":"Kostis","year":"2005","journal-title":"Arch Intern Med"},{"issue":"suppl\u00a01","key":"10.1016\/j.jaci.2016.09.051_bib15","first-page":"S11","article-title":"Phase 3, randomized, double-blind, placebo-controlled, multicenter clinical study evaluating the safety and efficacy of icatibant for angiotensin-converting enzyme inhibitor-induced angioedema in adults","volume":"23","author":"Sinert","year":"2016","journal-title":"Acad Emerg Med"},{"key":"10.1016\/j.jaci.2016.09.051_bib16","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.anai.2014.12.007","article-title":"Effectiveness of ecallantide in treating angiotensin-converting enzyme inhibitor-induced angioedema in the emergency department","volume":"114","author":"Bernstein","year":"2015","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaci.2016.09.051_bib17","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.annemergmed.2014.07.014","article-title":"Ecallantide for the acute treatment of angiotensin-converting enzyme inhibitor-induced angioedema: a multicenter, randomized, controlled trial","volume":"65","author":"Lewis","year":"2015","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.jaci.2016.09.051_bib18","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1161\/01.HYP.31.6.1299","article-title":"Acute ACE inhibition causes plasma extravasation in mice that is mediated by bradykinin and substance P","volume":"31","author":"Emanueli","year":"1998","journal-title":"Hypertension"},{"key":"10.1016\/j.jaci.2016.09.051_bib19","doi-asserted-by":"crossref","first-page":"703","DOI":"10.2215\/CJN.07371009","article-title":"Increased\u00a0incidence of angioedema with ACE inhibitors in combination with mTOR inhibitors in kidney transplant recipients","volume":"5","author":"Duerr","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.jaci.2016.09.051_bib20","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1111\/j.1398-9995.2010.02398.x","article-title":"Association of angiotensin-converting enzyme inhibitor-associated angioedema with transplant and immunosuppressant use","volume":"65","author":"Byrd","year":"2010","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2016.09.051_bib21","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1161\/HYPERTENSIONAHA.108.110270","article-title":"Angioedema incidence in US veterans initiating angiotensin-converting enzyme inhibitors","volume":"51","author":"Miller","year":"2008","journal-title":"Hypertension"},{"key":"10.1016\/j.jaci.2016.09.051_bib22","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1001\/jama.1997.03550030072037","article-title":"Recurrent angiotensin-converting enzyme inhibitor\u2013associated angioedema","volume":"278","author":"Brown","year":"1997","journal-title":"JAMA"},{"key":"10.1016\/j.jaci.2016.09.051_bib23","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.1002\/lary.24777","article-title":"Risk factors associated with severe and recurrent angioedema: an epidemic linked to ACE-inhibitors","volume":"124","author":"Loftus","year":"2014","journal-title":"Laryngoscope"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674916313768?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674916313768?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T09:08:53Z","timestamp":1758791333000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674916313768"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,7]]}},"alternative-id":["S0091674916313768"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2016.09.051","relation":{},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2017,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of bradykinin receptor antagonism on ACE inhibitor-associated angioedema","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2016.09.051","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}